← į stambius investuotojus
Boxer Capital Management, LLC
turto valdytojas · portfelis $1.33 mlrd. · 63 pozicijų · ataskaita 30.06.2026
Akcijų pozicijos ataskaita už 30.06.2026, pateikta 14.08.2026; pokytis — palyginti su 31.03.2026 · 66
| Įmonė | Akcijos | Vertė | portfelio % | Ketvirčio pokytis |
|---|---|---|---|---|
| Tango Therapeutics, Inc. US:TNGX | 10 876 219 | $340 mln. | 25.61% | — |
| Revolution Medicines, Inc. US:RVMD | 500 000 | $93.6 mln. | 7.05% | — |
| ABIVAX US:ABVX | 605 000 | $80.6 mln. | 6.07% | +405 000 |
| UNIQURE NV CUSIP N90064101 | 1 503 300 | $69.2 mln. | 5.21% | +841 300 |
| Kodiak Sciences Inc US:KOD | 1 477 600 | $57.6 mln. | 4.34% | +116 600 |
| Kymera Therapeutics Inc US:KYMR | 429 100 | $49.2 mln. | 3.71% | +100 000 |
| Definium Therapeutics, Inc. US:DFTX | 998 500 | $47.0 mln. | 3.54% | +400 000 |
| Replimune Group Inc US:REPL | 3 983 000 | $44.1 mln. | 3.32% | +2 808 000 |
| Celcuity LLC US:CELC | 416 530 | $43.6 mln. | 3.28% | +191 530 |
| Q32 Bio Inc US:QTTB | 3 149 310 | $40.1 mln. | 3.02% | nauja |
| Capricor Therapeutics Inc US:CAPR | 1 395 156 | $33.6 mln. | 2.53% | +805 156 |
| PRECIGEN, INC. US:PGEN | 5 150 000 | $29.4 mln. | 2.21% | +1 650 000 |
| Corcept Therapeutics Incorpo… US:CORT | 335 500 | $29.2 mln. | 2.20% | +85 500 |
| Surrozen Inc US:SRZN | 1 105 683 | $27.0 mln. | 2.03% | +339 365 |
| Protagonist Therapeutics Inc US:PTGX | 170 000 | $20.8 mln. | 1.57% | — |
| Vir Biotechnology Inc US:VIR | 1 866 000 | $19.0 mln. | 1.43% | — |
| Vaxcyte Inc US:PCVX | 325 000 | $18.9 mln. | 1.42% | — |
| UROGEN PHARMA LTD CUSIP M96088105 | 500 000 | $18.4 mln. | 1.39% | — |
| Corvus Pharmaceuticals Inc US:CRVS | 1 100 000 | $16.4 mln. | 1.24% | — |
| PTC Therapeutics Inc US:PTCT | 200 000 | $16.3 mln. | 1.23% | — |
| Praxis Precision Medicines I… US:PRAX | 46 457 | $15.6 mln. | 1.17% | — |
| Amylyx Pharmaceuticals Inc US:AMLX | 800 000 | $14.4 mln. | 1.08% | — |
| Ocular Therapeutix Inc US:OCUL | 1 300 000 | $12.8 mln. | 0.96% | +950 000 |
| Opus Genetics, Inc. US:IRD | 2 815 000 | $11.6 mln. | 0.87% | +565 000 |
| Palisade Bio Inc US:PALI | 4 799 875 | $10.0 mln. | 0.76% | — |
| APOGEE THERAPEUTICS INC CUSIP 03770N101 | 70 000 | $9.29 mln. | 0.70% | — |
| Spyre Therapeutics Inc. US:SYRE | 100 000 | $8.88 mln. | 0.67% | nauja |
| Cogent Biosciences Inc US:COGT | 225 000 | $8.71 mln. | 0.66% | — |
| Cytokinetics Inc US:CYTK | 100 000 | $8.52 mln. | 0.64% | — |
| Relay Therapeutics Inc US:RLAY | 450 000 | $8.42 mln. | 0.63% | nauja |
Mūsų duomenų bazės įmonėse 13
| Įmonė | Dalis | Akcijos | Ataskaitos data |
|---|---|---|---|
| Q32 Bio Inc | 10.58% | 3 149 310 | 2026-06-30 |
| Surrozen Inc | 9.52% | 1 105 683 | 2026-06-30 |
| Tango Therapeutics, Inc. | 6.45% | 10 876 219 | 2026-06-30 |
| Kazia Therapeutics Limited | 4.32% | 560 000 | 2026-06-30 |
| Replimune Group Inc | 4.2% | 3 983 000 | 2026-06-30 |
| Clene Inc. | 3.67% | 477 515 | 2026-06-30 |
| Opus Genetics, Inc. | 3.41% | 2 815 000 | 2026-06-30 |
| Inovio Pharmaceuticals Inc | 2.75% | 2 844 994 | 2026-06-30 |
| Capricor Therapeutics Inc | 2.4% | 1 395 156 | 2026-06-30 |
| Kodiak Sciences Inc | 2.35% | 1 477 600 | 2026-06-30 |
| Uniqure NV | 2.17% | 1 503 300 | 2026-06-30 |
| Edesa Biotech Inc | 2.13% | 205 000 | 2026-06-30 |
| AN2 Therapeutics Inc | 1.98% | 749 035 | 2026-06-30 |
reklama
